REQUEST A DEMO
Total
USD $0.00
Search more companies

Pharmagen Cz S.R.O. (Czech Republic)

Main Activities: All Other Professional, Scientific, and Technical Services
Full name: Pharmagen Cz S.R.O. Profile Updated: October 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Pharmagen Cz S.R.O. is based in Czech Republic, with the head office in Prague. The enterprise currently operates in the All Other Professional, Scientific, and Technical Services sector. It was established on October 14, 2010. Pharmagen Cz S.R.O. currently employs 10 - 19 (2024) people. In its most recent financial highlights, the company reported a net sales revenue drop of 14.16% in 2022. Its’ total assets recorded a negative growth of 3.97%. Pharmagen Cz S.R.O.’s net profit margin increased by 5.2% in 2022.

Headquarters
Reinerova 1712/9
Prague; The City of Prague; Postal Code: 16300

Contact Details: Purchase the Pharmagen Cz S.R.O. report to view the information.

Basic Information
Total Employees:
Purchase the Pharmagen Cz S.R.O. report to view the information.
Outstanding Shares:
Purchase the Pharmagen Cz S.R.O. report to view the information.
Registered Capital:
Purchase the Pharmagen Cz S.R.O. report to view the information.
Incorporation Date:
October 14, 2010
Key Executives
Purchase this report to view the information.
Legal Representative
Ownership Details
Purchase this report to view the information.
90%
Company Performance
Financial values in the chart are available after Pharmagen Cz S.R.O. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency CZK. Absolute financial data is included in the purchased report.
Net sales revenue
-14.16%
Total operating revenue
-14.37%
Operating profit (EBIT)
339.11%
EBITDA
416.31%
Net Profit (Loss) for the Period
259.97%
Total assets
-3.97%
Total equity
79.48%
Operating Profit Margin (ROS)
7.47%
Net Profit Margin
5.2%
Return on Equity (ROE)
22.21%
Quick Ratio
-0.15%
Cash Ratio
-0.02%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?